FindTrial
Sign In

Retinol-binding protein 4 (RBP4) and high sensitivity C-reactive protein (hs-CRP) levels in patients with diminished ovarian reserve (DOR): a prospective cross-sectional study

Retinol-binding protein 4 (RBP4) and high sensitivity C-reactive protein (hs-CRP) levels in patients with diminished ovarian reserve (DOR): a prospective cross-sectional study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000038305
Enrollment
Unknown
Registered
2020-09-17
Start date
2020-03-13
Completion date
Unknown
Last updated
2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diminished ovarian reserve

Interventions

diminished ovarian reserve group:Nil
normal ovarian reserve:Nil

Sponsors

Renmin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
21 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Infertile women aged 20-40 years; 2. Subjects with normal blood glucose and lipids; 3. Subjects with no family history of cardiovascular disease.

Exclusion criteria

Exclusion criteria: 1. Patients with or without any history of metabolic, endocrine and infectious diseases; 2. Obese (body mass index (BMI), >= 28 kg/m2); 3. Patients taking steroids or multivitamins containing vitamin A; 4. Patients with unilateral or bilateral ovarian surgery; 5. Patients with other fertility related factors, such as smoking, alcohol consumption and diet; 6. Patients with family history of cardiovascular disease or other metabolic diseases.

Design outcomes

Primary

MeasureTime frame
Retinol-binding protein 4 (RBP4) ;—

Countries

China

Contacts

Public ContactYang Jing

Renmin Hosipitai of Wuhan University

13507182023@163.com+86 13507182023

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026